TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
AVLN

Avalyn Pharma Inc.

Healthcare · Biotechnology

28.40$ +1.0% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement AVLN
Line item 2024 2025
– –
– +67.4%
– +29.2%
– +59.8%
– –
– –
– –
– –

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?